| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |